Today, the U.S. FDA approved tisotumab vedotin-tftv, an antibody-drug conjugate, for certain adult patients with recurrent or metastatic cervical cancer. bit.ly/3wosTPz The Agency had granted accelerated approval to the drug in September 2021.

.VIRGINIA KAKLAMANI and Aditya Bardia, MD discussed the Phase III Destiny-Breast06 trial, in which TDXd demonstrated improvement in PFS in patients with HR-positive, HER2-low and HER2-ultralow metastatic breast cancer. Watch now on SABCS Snippets:
bit.ly/3JHpw9q
UT Health San Antonio MD Anderson

The AACR Clinical Oncology Research (CORE) Training Fellowship provides $100,000 for clinical research fellows to spend one year onsite with an industry partner like AstraZeneca to gain real-world drug development experience. Apply by May 31:
bit.ly/4dhAYq0

How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases:
AACR Past President Dr. Elizabeth Jaffee and Harpreet Singh will chair this AACR-U.S. FDA workshop. Join us May 9 in Bethesda, MD, or online. Learn more:
bit.ly/4aUSQoX
#AACRSciencePolicy Harpreet Singh, MD

Register by April 29 to get the lowest rates for the AACR Special Conference on Expanding and Translating Cancer Synthetic Vulnerabilities (June 10-13, Montreal), chaired by Stegmaier Lab, Alejandro Sweet-Cordero, MD, Michael Erb, and Kris C. Wood.
bit.ly/3JEFUYs
#AACRsynth24

.Margaret Foti, PhD, MD (hc) Margaret Foti discussed the AACR’s long-standing commitment to reducing cancer disparities and achieving health equity during a panel discussion today at the Binaytara Foundation’s Summit on Cancer Health Disparities.
#SCHD24

FDA regulators get cancer, too, and care for loved ones with cancer. How does that experience inform their perspectives on advancing safe and effective cancer therapies? Watch this moving #AACR2024 session with FDA Oncology staff members.
vimeo.com/937846719?shar…
#OCETalks

Current Landscape for Perioperative Trial Designs: Erin Larkins, MD, will moderate this session at the FDA Oncology-AACR workshop on Trial Designs for Treatment Regimens with Multiple Phases (May 9). Learn more:
bit.ly/3Jy4ytP
#AACRSciencePolicy

New Technologies to Discover Synthetic Lethality:
LukeGilbert, Francisco J. Sánchez Rivera, and Kristen L. Karlin will address this topic in a plenary at the AACR Conference on Cancer Synthetic Vulnerabilities (June 10-13, Montreal).
bit.ly/3y29Hrf
#AACRsynth24

Submit an abstract by June 18 for the Ovarian Cancer Research Symposium (September 20-21, Seattle), presented by the Rivkin Center and the AACR. Learn more:
bit.ly/4aaWDO1

Register by May 8 to get the lowest rates for the AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia), chaired by Michael R. Green and organized in association with Blood Cancer Discovery. Learn more:
bit.ly/49TwfYO
#AACRlymph24 Michael Green, PhD

Submit an abstract by June 18 for the AACR Conference on Pediatric Cancer (Sept 5-8, Toronto), chaired by Alejandro Gutierrez, Cynthia E. Hawkins, Andrea A. Hayes, and Gilles Vassal.
bit.ly/3WjaSNq
#AACRpediatric24 Alejandro Gutierrez Hawkins Lab Andrea A. Hayes, MD Gilles Vassal

The AACR Scientist↔Survivor Program® welcomes patient advocates to the AACR Annual Meeting, where they share their perspective with scientist and physician mentors while learning about cutting-edge research. Learn more in Cancer Today:
bit.ly/3vYQxCl
#AACRSSP #AACR24

Lymphoma Clonal Precursors and Transformation:
Ari M. Melnick, Sandrine Roulland, and Erin Parry, MD PhD will address this topic in a plenary at the AACR Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia).
bit.ly/44g9flk
#AACRlymph24 Melnick Lab Sandrine Roulland

We congratulate the #AACRFellows who have been elected to the American Academy of Arts and Sciences:
–Kornelia Polyak, MD, PhD
–Michel Sadelain, MD, PhD
–David A. Tuveson, MD, PhD
–Arlene H. Sharpe, MD, PhD
–Eileen P. White, PhD
bit.ly/3UvGYUC
American Academy of Arts & Sciences

Register by April 29 to get the lowest rates for the AACR Special Conference on Expanding and Translating Cancer Synthetic Vulnerabilities (June 10-13, Montreal), chaired by Stegmaier Lab, Alejandro Sweet-Cordero, MD, Michael Erb, and Kris C. Wood.
bit.ly/3Ql0kt4
#AACRsynth24

Apply by May 13 for the Robert A. Winn Diversity in Clinical Trials Career Development Award. This two-year program for early-career physicians committed to diversity in clinical research trains them to become independent clinical trial investigators:
bit.ly/3xUyWvS

Submit an abstract by June 6 for the AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved (September 21-24, Los Angeles), organized in association with #AACRMICR .
bit.ly/3Qmqb3V
#AACRdisp24 Melissa B Davis, PhD

The Victoria’s Secret Global Fund for Women’s Cancers Career Development Awards, in partnership with Pelotonia & AACR, are two-year, $206,000 grants supporting female early-stage investigators researching breast and gynecologic cancers. Apply by May 15: bit.ly/4bseOzN

Join us online May 6-9 for the 12th Annual Symposium on Global Cancer Research, a virtual event highlighting cancer research and control programs that address the global burden of cancer. Learn more:
bit.ly/44g1lbz
#ASGCR24